Insider Transactions in Q3 2022 at Mirati Therapeutics, Inc. (MRTX)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 07
2022
|
Jamie Christensen EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,149
+15.29%
|
-
|
|
Aug 12
2022
|
Bruce L A Carter |
SELL
Open market or private sale
|
Direct |
10,000
-38.35%
|
$850,000
$85.5 P/Share
|
|
Aug 12
2022
|
Bruce L A Carter |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+38.43%
|
$270,000
$27.0 P/Share
|